期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 59, 期 6, 页码 3663-3665出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00004-15
关键词
-
资金
- Section of Hygiene and Medical Microbiology, Innsbruck Medical University
- Austrian Science Fund (FWF)
- MFF Tirol
- Astellas Pharma
- Gilead Sciences
- Pfizer
- Schering Plough
- Merck Sharp Dohme
- Astellas
Amphotericin B and posaconazole susceptibility patterns were determined for the most prevalent Mucorales, following EUCAST (European Committee on Antimicrobial Susceptibility Testing) broth microdilution guidelines. In parallel, Etest was performed and evaluated against EUCAST. The overall agreement of MICs gained with Etest and EUCAST was 75.1%; therefore, Etest cannot be recommended for antifungal susceptibility testing of Mucorales. Amphotericin B was the most active drug against Mucorales species in vitro, while the activities of posaconazole were more restricted.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据